Acta Colombiana de Cuidado Intensivo, Journal Year: 2023, Volume and Issue: 24(1), P. 61 - 67
Published: Aug. 1, 2023
Frontiers in Global Women s Health, Journal Year: 2025, Volume and Issue: 5
Published: Jan. 6, 2025
•Massive pulmonary embolism (PE) during pregnancy or the postpartum period is a rare but potentially lethal event.•Physiological changes in coagulation system and puerperium would lead to hypercoagulable state.•Diagnosis of PE remains challenge due physiological pregnancy. There are no validated scoring systems for assessing pregnant/postpartum women with suspected PE. Massive should be all cases haemodynamic instability pregnancy.•The Management massive timely aggressive. Thrombolysis has shown associated high maternal fetal survival (94% 88%). But other therapeutic options such as (catheter [or surgical] thrombectomy, ECMO) considered period, given risk major bleeding thrombolysis.•Thrombolysis most-used reasonably successful modality treatment avoided it can cause life-threatening haemorrhage. During post-partum thrombectomy choice. •To understand pathophysiology PE.•To appreciate their pros cons.•To need further work this area especially creating algorithm diagnosing period.
Language: Английский
Citations
0
The Journal of Maternal-Fetal & Neonatal Medicine, Journal Year: 2025, Volume and Issue: 38(1)
Published: Jan. 29, 2025
Objective There is an increase in the application data of Extracorporeal Membrane Oxygenation (ECMO) perinatal women, particularly since outbreak coronavirus disease 2019. Therefore, we reviewed publications on use ECMO pregnant and postpartum women analyzed maternal fetal outcomes, updated progress women.
Language: Английский
Citations
0
Placenta, Journal Year: 2025, Volume and Issue: unknown
Published: May 1, 2025
Language: Английский
Citations
0
Resuscitation Plus, Journal Year: 2025, Volume and Issue: unknown, P. 100983 - 100983
Published: May 1, 2025
Language: Английский
Citations
0
Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(6), P. 1634 - 1634
Published: March 13, 2024
Extracorporeal membrane oxygenation (ECMO) is a cardiac or pulmonary function support system that used in cases of refractory organ failure addition to conventional treatment. Currently, Level I evidence not yet available, which reflects improved outcomes with ECMO pregnant women, the use pregnancy should be indicated selected and only specialized centers. We searched articles most important scientific databases from 2009 until 31 December 2023 consulting also site ClinicalTrials.com find out about studies have been recently conducted are currently ongoing. matched combination following keywords: “ECMO pregnancy”, “H1N1 “COVID-19 “ARDS AND (cardiac arrest)”. number for each keyword combination: pregnancy” (665 articles); influenza H1N1” (384 “pregnancy (1006 ARDS” (2930 ARDS (24 “[ECMO arrest)]” (74 articles). After careful inspection, 43 papers fitted our scope. There two types ECMO: venous-venous (VV-ECMO) venous-arterial (VA-ECMO). The first-one necessary cope severe hypoxia: oxygen-depleted blood taken venous circulation, oxygenated, carbon dioxide removed extracorporeal circuit returned same system. VA-ECMO type mechanical assistance circulatory allows put failing at rest by ensuring adequate systemic de-oxygenation, avoiding multi-organ failure. main indications women cardiogenic shock, acute respiratory distress syndrome (ARDS), embolism, eclampsia. fetal ECMO, they distress, hypoxic-ischemic encephalopathy (HIE), twin-to-twin transfusion (TTTS). Until now, based on numerous clinical conducted, has shown successful therapeutic strategy where medical treatment unsuccessful. In well-selected patients, it appears safe associated low risk maternal complications. aim this review report properties (VV VA) its women.
Language: Английский
Citations
2
The Journal of Maternal-Fetal & Neonatal Medicine, Journal Year: 2024, Volume and Issue: 37(1)
Published: Jan. 2, 2024
Extracorporeal membrane oxygenation (ECMO) use in peripartum patients is rare, and there a gap the literature on outcomes guidance using ECMO patients. This study describes strategies our institution uses for reports of with respiratory and/or cardiac failure.
Language: Английский
Citations
2
British Journal of Anaesthesia, Journal Year: 2023, Volume and Issue: 131(4), P. e130 - e132
Published: Aug. 4, 2023
Language: Английский
Citations
5
Die Anaesthesiologie, Journal Year: 2024, Volume and Issue: 73(6), P. 385 - 397
Published: April 26, 2024
Zusammenfassung Hintergrund Schwangere mit einer SARS-CoV-2-Infektion (COVID-19) haben ein erhöhtes Risiko für einen schweren Verlauf der COVID-19. Die medizinische und ethische Abwägung maternaler fetaler Risiken die Priorisierung von Therapieoptionen stellen eine große Herausforderung auf Intensivstation dar. Eine enge interdisziplinäre Abstimmung ist unabdingbar. Ziel Arbeit Beschreibung Diskussion intensivmedizinischer Behandlungsstrategien des perinatalen anästhesiologischen Managements bei Patientinnen COVID-19-ARDS (CARDS). Material Methoden Analyse demografischen Daten, Anamnese, klinischem Management, Komplikationen, Indikationen Management extrakorporalen Membranoxygenierung (ECMO) sowie kindlichen Überlebens aller schwangeren Patientinnen, zwischen März November 2021 eines deutschen Universitätsklinikums wegen CARDS behandelt wurden. Ergebnisse Kohorte 9 konsekutiven einem Durchschnittsalter 30,3 Jahren (Min–Max: 26 bis 40 Jahre) Schwangerschaftsalter 21 + 3 37 2 Wochen. Keine war gegen SARS-CoV‑2 geimpft. Zwei mussten inhalativem Stickstoffmonoxid venovenöser ECMO werden. Alle Frauen 5 Neugeborene überlebt. wurden intakter Schwangerschaft nach Hause entlassen. Kinder durch Kaiserschnitt entbunden. Es intrauterine fetale Todesfälle beobachtet. Keines Neugeborenen wurde Geburt positiv getestet. Das peripartale erfordert Zusammenarbeit sollte in Frühschwangerschaft vorrangig das mütterliche Überleben ausgerichtet sein. Bauchlagerung, wesentlicher, evidenzbasierter Eckpfeiler Therapie akuten Atemnotsyndroms (ARDS), kann auch fortgeschrittenen Schwangerschaftsstadien sicher angewendet Inhalatives (iNO) extrakorporale sollten als lebensrettende Behandlungsoptionen sorgfältig ausgewählte Betracht gezogen
Citations
1
International Journal of Obstetric Anesthesia, Journal Year: 2024, Volume and Issue: 60, P. 104247 - 104247
Published: Aug. 8, 2024
Language: Английский
Citations
1
ASAIO Journal, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 9, 2024
Cases of antepartum respiratory failure or cardiogenic shock treated successfully with extracorporeal life support (ECLS) high rates survival for both mother and fetus are well documented. In contrast, there is a paucity literature on the outcomes these neonates after delivery. We report single-center retrospective study all adult cases ECLS from February 2015 to April 2023 neonatal follow-up. Seven patients met inclusion criteria maternal age 32.0±5.5 years (median ± interquartile range [IQR]), primarily due in six (86%) patients, initiation at 27.0±3.0 weeks gestation. All mothers fetuses survived delivery gestational 29.0±4.5 weeks. discharge home most common comorbidities being prematurity seven (100%) bronchopulmonary dysplasia three (43%). follow-up period 1.4±1.2 years; four (57%) underwent formal neurodevelopmental testing two (50%) had identified delays, related speech/language. These results suggest that children exposed antenatal demonstrate without significant morbidity, but delays may be warranted.
Language: Английский
Citations
1